Early Palliative Care for Patients With Haematological Malignancies

• Status: Recruiting
• Trial end date: 2023-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Patients suffering from haematological disease present symptoms of discomfort and currently benefit from palliative care skills only for the management of their end-of-life. However, in medical oncology, more and more studies tend to demonstrate the benefit on the quality of life of an early collaboration between the two specialties.

Investigator did the hypothesis that early integration of palliative care with conventional haematological care could decrease discomfort symptoms and add a real benefit on the patients' quality of life .

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Collaborators: Association CEMSBM; Association des foulées de la Haute Lozère; Connaître et Combattre les Myélodysplasies; Fondation Apicil

Criteria

Inclusion Criteria:

• Patients are over 70 years old

• Patients from being diagnosed with acute myeloid leukemia and high-risk myelodysplastic syndrome or after the third line of therapy for high-grade lymphoma.

Exclusion Criteria:

• All patients with a curative project (induction chemotherapy ou allogenic transplantation)

• All patients in a terminal palliative status

• Patients who don't speak French,

• Patients not able to read and write

• Patients who don't agree to participate in the protocol

• Patients with psychiatric troubles or cognitive disorders

• Patients under guardianship or curatorship, deprived of freedom or under justice protection.